Full-Time

Senior Director

PDM Product Strategy Leader

Confirmed live in the last 24 hours

Gilead Sciences

Gilead Sciences

10,001+ employees

Develops and commercializes biopharmaceuticals

Compensation Overview

$243.1k - $314.6k/yr

+ Bonus + Stock-based long-term incentives

Senior, Expert

Company Historically Provides H1B Sponsorship

San Mateo, CA, USA

Category
Project Management
Strategy Development
Business & Strategy
Requirements
  • A degree in science, engineering, or technical field with directly relevant professional experience of at least 14 years with a BA/BS or 12 years with an MA/MS, PhD, PharmD, or MD.
  • Demonstration of outcome-oriented team leadership in some aspects of pharmaceutical manufacturing, or supply chain, or quality, or CMC regulatory, or process development, or as part of a cross-functional product team in the broader pharmaceutical industry.
Responsibilities
  • Lead strategic cross-functional teams responsible for all technical and CMC aspects of assigned products.
  • Translate business strategy and PST vision into the PDM plan for execution.
  • Direct Process Development and Analytical Development teams to ensure effective and timely progression of pipeline projects and CMC life-cycle planning.
  • Develop and own the product technical plan including timelines, multi-year budgets and critical deliverables.
  • Ensure end-to-end design, execution and risk mitigation activities across Process, Formulation and Analytical work packages from FIH through commercialization.
  • Identify process, analytical development, and control system risks and develop mitigation plans.
  • Prepare annual revisions to the technical strategic plans for the products.
  • Accountable for clear and timely communication to senior leadership on product activities throughout the enterprise against deliverables, timelines, and resources.
  • Support other PDM Product Leaders in building a peer-group community with a range of technical backgrounds and experience through ongoing strategic coaching and skill development.
  • Coach early in-career development scientists and engineers, and others working on the product team.
Desired Qualifications
  • Strong influencing skills to effectively lead in a highly matrixed environment with minimal positional authority within the enterprise product teams and across PDM.
  • Cross-functional and enterprise-wide relationship building skills.
  • A strong business process orientation but able to deploy processes practically and with the maximum impact.
  • Knowledgeable in cGMP manufacturing and regulatory regulations and requirements for biologics and/or small molecules.
  • Ability to work in a dynamic environment with multiple products and modalities.
  • Strength in coaching and mentoring scientists and engineers across functional areas.
  • Strong interpersonal, verbal, and written communication skills with the ability to synthesize complex situations, illustrate conceptual paths, and facilitate discussions leading to resolution on key issues.
  • Ability to work efficiently and independently in a changing environment.
  • Comfort with assuming responsibility and accountability for taking impactful decisions.
  • Strong business and strategic skills – for example, converting the high-level goals for a product into a coherent plan for prioritized activities within PDM to support and deliver against those goals.

Gilead Sciences is a biopharmaceutical company that develops and sells medicines for various serious health conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company focuses on extensive research and development to create new therapies, which are then approved by regulatory authorities before being marketed to healthcare providers, hospitals, and pharmacies. Gilead stands out from its competitors by investing heavily in R&D and forming strategic partnerships, such as with SAP Ariba, to improve its supply chain and ensure sustainable practices. The company's goal is to enhance health equity and access to care globally, working with communities to remove barriers to healthcare and make its medicines available to those in need.

Company Size

10,001+

Company Stage

IPO

Headquarters

Foster City, California

Founded

1987

Simplify Jobs

Simplify's Take

What believers are saying

  • Gilead's $32 billion U.S. investment will create over 3,000 jobs by 2028.
  • The reformulation of lenacapavir offers long-acting HIV prevention, improving patient adherence.
  • Gilead's top five ranking in the Most JUST list highlights its corporate responsibility.

What critics are saying

  • A $202 million settlement for legal violations may damage Gilead's reputation.
  • Layoffs of 150 employees, including senior management, could disrupt company operations.
  • AI-driven drug discovery companies pose a competitive threat to Gilead's traditional R&D.

What makes Gilead Sciences unique

  • Gilead focuses on innovative medicines for unmet needs like HIV/AIDS and liver diseases.
  • The company invests heavily in R&D to maintain a robust pipeline of new treatments.
  • Gilead's partnerships enhance product offerings and expand market reach globally.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Company News

Fierce Pharma
May 8th, 2025
Gilead tees up $11B in new US manufacturing, R&D investments

This time it's Gilead coming to the table with a fresh $11 billion in hand to spend across its manufacturing and research centers in the U.S.

Gilead Sciences
May 7th, 2025
Gilead U.S. Investment to Create $43 Billion in Value to U.S. Economy

Gilead to invest $32 billion in U.S. manufacturing and R&D through 2030 and create more than 3,000 direct and indirect jobs by 2028

Constantine Cannon
May 5th, 2025
Gilead Pays $202M to Settle False Claims Act Kickback Charges

On April 29, the Department of Justice (DOJ) announced that California-based pharmaceutical giant Gilead Sciences agreed to pay $202 million to settle charges of violating the False Claims Act and Anti-Kickback Statute.

Financial Modeling Prep
May 2nd, 2025
Amgen Inc. (NASDAQ:AMGN) Surpasses Earnings and Sales Estimates in Q1 2025

Amgen competes with other biotech giants like Gilead Sciences and Biogen.

SFist
Apr 2nd, 2025
April Fool's Day Around the Bay: Bob Lee's Family Has Sued His Convicted Killer Nima Momeni

Foster City-based HIV drug company Gilead Sciences is laying off nearly 150 people, and the job cuts are significant among senior members of the company's management.